Soleno Therapeutics (SLNO) Short Interest Ratio & Short Volume → Dollar Cancelled (From Lear Capital) (Ad) Free SLNO Stock Alerts $45.94 +0.82 (+1.82%) (As of 05/6/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Soleno Therapeutics Short Interest DataCurrent Short Volume3,100,000 sharesPrevious Short Volume2,760,000 sharesChange Vs. Previous Month+12.32%Dollar Volume Sold Short$119.41 millionShort Interest Ratio / Days to Cover10.2Last Record DateApril 15, 2024Outstanding Shares33,410,000 sharesFloat Size19,730,000 sharesShort Percent of Float15.71%Today's Trading Volume291,014 sharesAverage Trading Volume543,597 sharesToday's Volume Vs. Average54% Short Selling Soleno Therapeutics ? Sign up to receive the latest short interest report for Soleno Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatSLNO Short Interest Over TimeSLNO Days to Cover Over TimeSLNO Percentage of Float Shorted Over Time Ad Lear CapitalDollar CancelledDon’t wait to protect your hard-earned savings. Top economists and billionaires are predicting that the dollar could collapse before the end of 2024.Get informed and prepare now before it’s too late. Soleno Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20243,100,000 shares $119.41 million +12.3%15.7%10.2 $38.52 3/31/20242,760,000 shares $118.13 million +20.0%14.6%9 $42.80 3/15/20242,300,000 shares $99.96 million +36.9%12.2%7.8 $43.46 2/29/20241,680,000 shares $81.18 million +11.3%9.5%4.9 $48.32 2/15/20241,510,000 shares $70.17 million -0.7%8.5%4.8 $46.47 1/31/20241,520,000 shares $70.45 million +8.6%8.4%4.7 $46.35 Get the Latest News and Ratings for SLNO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Soleno Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/20241,400,000 shares $58.51 million +4.5%7.8%4.4 $41.79 12/31/20231,340,000 shares $53.94 million +77.0%7.3%4 $40.25 12/15/2023756,900 shares $28.68 million +10.8%4.1%0.6 $37.89 11/30/2023683,300 shares $20.34 million +17.9%3.9%0.6 $29.76 11/15/2023579,500 shares $13.62 million -15.0%3.3%0.5 $23.51 10/31/2023682,000 shares $16.27 million +4.8%4.2%0.6 $23.85 10/15/2023650,500 shares $15.77 million -58.6%4.0%0.6 $24.25 9/30/20231,570,000 shares $46.33 million +683.0%15.7%1.5 $29.51 9/15/2023200,500 shares $982,450.00 +151.9%2.5%0.3 $4.90 8/31/202379,600 shares $389,244.00 -3.2%1.0%1.4 $4.89 8/15/202382,200 shares $371,544.00 +13.7%1.1%1.3 $4.52 7/31/202372,300 shares $368,730.00 -12.8%1.2%0.7 $5.10 7/15/202382,900 shares $446,002.00 +14.0%1.3%0.8 $5.38 6/30/202372,700 shares $311,883.00 -19.1%1.2%0.7 $4.29 6/15/202389,900 shares $449,500.00 -9.1%1.4%0.8 $5.00 5/31/202398,900 shares $521,203.00 +39.3%1.6%1 $5.27 5/15/202371,000 shares $298,555.00 +14.7%1.3%0.8 $4.21 4/30/202361,900 shares $208,603.00 -42.8%1.4%1.3 $3.37 4/15/2023108,200 shares $349,486.00 +27.6%1.9%1.7 $3.23 3/31/202384,800 shares $181,472.00 -7.3%1.5%1.1 $2.14 3/15/202391,500 shares $187,575.00 -16.1%1.6%0.3 $2.05 2/28/2023109,000 shares $221,270.00 -1.0%1.9%0.1 $2.03 2/15/2023110,100 shares $214,695.00 -40.3%2.5%0.1 $1.95 1/31/2023184,300 shares $536,313.00 -30.6%4.1%0.1 $2.91 1/15/2023265,400 shares $631,652.00 -55.1%6.0%0.1 $2.38 12/30/2022590,900 shares $1.17 million +498.1%13.3%0.3 $1.98 12/15/202298,800 shares $88,129.60 +14.8%2.2%0.1 $0.89 11/30/202286,100 shares $92,988.00 +65.3%1.9%1.3 $1.08 11/15/202252,100 shares $56,789.00 +10.2%1.2%0.5 $1.09 10/31/202247,300 shares $46,827.00 +65.4%1.1%0.5 $0.99 10/15/202228,600 shares $38,038.00 -53.0%0.7%0.3 $1.33 9/30/202260,900 shares $101,703.00 +13.8%1.4%0.5 $1.67 9/15/202253,500 shares $115,025.00 +21.6%1.3%0.4 $2.15 8/31/202244,000 shares $96,800.00 -94.5%1.0%0.3 $2.20Urgent Alert: Is the U.S. Implementing a Digital Dollar? (Ad)Our exclusive guide, "Exploring the Future of the U.S. Dollar in a Digital World," is your essential resource in navigating this uncertain terrain. Inside, you'll find expert insights, strategies, and actionable steps to shield your wealth from the impending digital dollar storm.Limited time offer! Claim your guide today and stay ahead of the digital dollar revolution. SLNO Short Interest - Frequently Asked Questions What is Soleno Therapeutics' current short interest? Short interest is the volume of Soleno Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 3,100,000 shares of SLNO short. 15.71% of Soleno Therapeutics' shares are currently sold short. Learn More on Soleno Therapeutics' current short interest. What is a good short interest ratio for Soleno Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SLNO shares currently have a short interest ratio of 10.0. Learn More on Soleno Therapeutics's short interest ratio. What is a good short interest percentage for Soleno Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 15.71% of Soleno Therapeutics' floating shares are currently sold short. Is Soleno Therapeutics' short interest increasing or decreasing? Soleno Therapeutics saw a increase in short interest in April. As of April 15th, there was short interest totaling 3,100,000 shares, an increase of 12.3% from the previous total of 2,760,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Soleno Therapeutics' float size? Soleno Therapeutics currently has issued a total of 33,410,000 shares. Some of Soleno Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Soleno Therapeutics currently has a public float of 19,730,000 shares. How does Soleno Therapeutics' short interest compare to its competitors? 15.71% of Soleno Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Soleno Therapeutics: InMode Ltd. (6.58%), CONMED Co. (12.63%), BioLife Solutions, Inc. (6.84%), Rhythm Pharmaceuticals, Inc. (16.73%), Larimar Therapeutics, Inc. (5.69%), Edap Tms S.A. (0.23%), FONAR Co. (0.13%), Rockwell Medical, Inc. (2.40%), LivaNova PLC (5.71%), TransMedics Group, Inc. (19.35%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Soleno Therapeutics stock? Short selling SLNO is an investing strategy that aims to generate trading profit from Soleno Therapeutics as its price is falling. SLNO shares are trading up $0.82 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Soleno Therapeutics? A short squeeze for Soleno Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SLNO, which in turn drives the price of the stock up even further. How often is Soleno Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SLNO, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: INMD Short Interest Data CNMD Short Interest Data BLFS Short Interest Data RYTM Short Interest Data LRMR Short Interest Data EDAP Short Interest Data FONR Short Interest Data RMTI Short Interest Data LIVN Short Interest Data TMDX Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SLNO) was last updated on 5/7/2024 by MarketBeat.com Staff From Our PartnersThe #1 lithium battery stock to have on your radar in 2024!Smallcaps DailyDollar CancelledLear CapitalUrgent Alert: Is the U.S. Implementing a Digital Dollar?Gold Gate CapitalDave Ramsey Shocks Millions With US Dollar LunacyAmerican Hartford Gold GroupTrump is sounding the alarmPreserve GoldBiden’s Sneaky H.R. 5376 Is A Nightmare For Retirement SaversBirch GoldBiden’s $374B Giveaway Into This SectorDTIAI “wealth window” is closing June 25thParadigm Press